All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2008-001807-53 | Essai de phase II d’évaluation de l’efficacité et de la tolérance du bevacizumab (AVASTIN®) dans les cancers du sein inflammatoire HER2-. | 2019-09-26 | due-trials |